Your session is about to expire
← Back to Search
SIESTA Rehab Education for Stroke Recovery
Study Summary
This trial will test whether the SIESTA-Rehab intervention leads to better sleep and improved recovery for stroke patients during acute rehabilitation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have serious heart conditions or diseases like MS, Alzheimer's, or Parkinson's.You are currently staying at the Shirley Ryan AbilityLab due to a stroke.I am 18 years old or older.You have a powered heart monitoring or support device implanted, like a pacemaker or defibrillator.I have skin allergies, irritations, or open wounds.
- Group 1: SIESTA Rehab
- Group 2: Control Unit
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the primary objective of this experiment?
"This inpatient trial seeks to quantify changes in sleep duration with secondary objectives of analysing 6-Minute Walk Test results, evaluating functional balance with the Berg Balance Scale, and monitoring mobility via activity counts. Patients are expected to stay for an average of 17 days while undergoing continuous observation."
Are there any available openings to participate in this research?
"Per clinicaltrials.gov, this particular study has stopped recruiting patients since it was last updated on August 18th 2022; however, there are currently over 1400 other medical trials that are presently seeking candidates for participation."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger